Related Experiment Videos
[Quantification analysis of vascular endothelial cells in human solid tumor]
1Center for Biotherapy of Cancer, Center of Oncology, First Affiliated Hospital, WCUMS, Chengdu 610041.
Hua Xi Yi Ke Da Xue Xue Bao = Journal of West China University of Medical Sciences = Huaxi Yike Daxue Xuebao
|January 8, 2003
Summary
Quantifying tumor angiogenesis is crucial for cancer prognosis. This study introduces flow cytometry using anti-CD34 antibodies as a precise and rapid method for measuring tumor vascularity, outperforming traditional immunohistochemistry.
Area of Science:
- Oncology
- Vascular Biology
- Biotechnology
Context:
- Tumor angiogenesis, the formation of new blood vessels within a tumor, is vital for solid tumor growth and metastasis.
- Accurate quantification of tumor angiogenesis is challenging but essential for patient prognosis across various malignancies.
- Intratumoral microvessel density is a recognized prognostic marker, yet precise measurement methods remain limited.
Purpose:
- To evaluate flow cytometry as a novel, accurate, and rapid method for quantifying tumor angiogenesis.
- To compare the efficacy of flow cytometry with established immunohistochemistry techniques for assessing tumor vascularity.
- To establish a correlation between endothelial cell quantification by flow cytometry and microvessel counts via immunohistochemistry.
Summary:
- Endothelial cells in 20 solid tumors were labeled with fluorescent anti-CD34 antibodies and quantified using flow cytometry.
- Results showed a significant difference between treatment and control groups, indicating flow cytometry's sensitivity.
- A significant correlation was observed between the percentage of endothelial cells measured by flow cytometry and microvessel counts determined by immunohistochemistry (CD34 and Factor VIII staining).
Impact:
- Flow cytometry offers a precise and rapid alternative for quantifying tumor angiogenesis, overcoming limitations of traditional methods.
- This technique can improve the accuracy of prognostic assessments in cancer patients.
- The findings support the clinical utility of flow cytometry in cancer research and diagnostics for evaluating tumor vascularization.